Boston Scientific Corporation (NYSE:BSX) climbed 1.47% to $6.91. The company announced the U.S. Food and Drug Administration clearance of the ACUITY Break-Away Lead Delivery System for use with cardiac resynchronization therapy defibrillators (CRT-Ds) and cardiac resynchronization therapy pacemakers (CRT-Ps), both of which treat heart failure. Over the last 52 weeks the stock has ranged from a low of $6.30 to a high of $11.77.
Subscribe to daily free stock newsletter by visiting: http://www.pennystockpickreport.com/
Medtronic, Inc. (NYSE:MDT) went up 0.18% and is trading at $43.38. The company today released new evidence demonstrating that key shock-reduction programming strategies significantly reduced implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) shocks from 17 to 28 percent. The study also identified programming and patient characteristics that increased the risk of shocks. Over the last 52 weeks the stock has ranged from a low of $31.02 to a high of $46.66.
St. Jude Medical, Inc. (NYSE:STJ) added 1.20% to $39.66. The company announced the U.S. Food and Drug Administration (FDA) approval and first U.S. implants of its Unify cardiac resynchronization therapy defibrillator (CRT-D) and Fortify implantable cardioverter defibrillator (ICD). The new devices feature advanced battery technology and circuitry that allow for the smallest device footprint in the industry and rapid charge times, without any compromise in device longevity or power. Over the last 52 weeks the stock has ranged from a low of $31.66 to a high of $42.87.
About http://www.pennystockpickreport.com/
Penny Stock Pick Report offers stock news on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.